Leadership & Pay ·
On August 31, 2026, BioForce Nanosciences Holdings, Inc. issued 4,516,909 restricted shares of common stock in a…
BFNHBioforce Nanosciences Holdings, Inc.
On August 31, 2026, BioForce Nanosciences Holdings, Inc. issued 4,516,909 restricted shares of common stock in a private placement exempt from registration under Section 4(2) of the Securities Act. The company received no cash proceeds; instead, the shares were issued as compensation for services valued at $2,484,300. No commissions or fees were paid in connection with the transaction. BioForce Nanosciences Holdings, Inc. operates in the nanotechnology industry, developing and commercializing nano-enabled products.